天美传媒

Larry S. Schlesinger, MD is an internationally recognized authority in infectious diseases with a particular interest in tuberculosis and lung biology. He earned a BA in Biology from Cornell University and MD from Rutgers Medical School. He completed his residency in Internal Medicine at the University of Michigan and clinical and research fellowships in Infectious Diseases at UCLA. He joined the faculty at the University of Iowa in 1991 where he served as Fellowship Director for the Division of Infectious Diseases and Associate Chair of the Department of Medicine. He moved to the Ohio State University in 2002 where he served as Director of the Division of Infectious Diseases, Department of Internal Medicine until 2011 when he became first chair of Microbial Infection & Immunity. During his tenure he founded the Center for Microbial Interface Biology, a Board of Trustees approved university-wide center with a focus on infectious diseases of concern to public health. In 2017 he became President and CEO of Texas Biomedical Research Institute in San Antonio, TX. 
Dr. Schlesinger is a leading physician scientist whose studies focus on the pathogenesis of tuberculosis and other airborne infectious agents that subvert lung immune mechanisms. His discoveries have led to greater insight into the unique attributes that soluble and cellular components of the innate immune system of humans bring to the microbe-host interface (with a focus on human macrophages), translating them into drug discovery platforms. He is a prolific scholar, having authored more than 170 peer-reviewed articles, served as editor of 2 books and has written several chapters in leading textbooks on tuberculosis and lung biology. He has been continually funded for nearly 30 years by the National Institutes of Health (NIH) and other federal agencies as well as private foundations such as the Bill & Melinda Gates Foundation.
He is a current NIH NIAID Council member, Fellow of the American Association for the Advancement of Science, Association of American Physicians and American Academy of Microbiology, and OSU鈥檚 2011 Distinguished Scholar and 2105 COM Distinguished Professor.

In 2009, she joined the Department of Pathology & Molecular Medicine at McMaster University and was promoted to associate professor in 2014. In 2019, she was promoted to tenure professor in the same department. The Bowdish lab focuses primarily on the effects of aging on the immune system, specifically macrophages. Her lab has been able to elucidate a mechanistic explanation for how aging alters myeloid cells and how these cells increase susceptibility to pneumococcal pneumonia. In 2017, the Bowdish lab demonstrated that age-associated gut microbe dysbiosis in mice increases age-associated inflammation. Bowdish currently holds an h-index score of 38. Bowdish's published works have received much media attention and continue to contribute more information regarding the interplay between the immune system, the gut microbiota, susceptibility to infection and aging.

Larry K. Kociolek, MD is an Attending Physician, Infectious Diseases; Associate Medical Director, Infection Prevention and Control; Irene Heinz Given and John La Porte Given Professorship in Pediatrics and Assistant Professor of Pediatrics, Northwestern University Feinberg School of Medicine. 

With interest in the areas of healthcare epidemiology and infection prevention and control, particularly Clostridium difficile infections, infections caused by antibiotic-resistant bacteria, infections in immunocompromised children, Kawasaki Disease. Other areas of investigation include the use of whole-genome sequencing to assess antibiotic resistance determinants and virulence factors of emerging strains of C. difficile, namely DH/NAP11/106, as well as identifying transmission and evolution of C. difficile clones in a pediatric population.

The research interests of Bobbi S. Pritt, M.D., are in clinical parasitology, vector-borne diseases, trainee education, and appropriate test utilization.

As director of the Clinical Parasitology Laboratory in Mayo Clinic's Department of Laboratory Medicine and Pathology, Dr. Pritt has coordinated the development of real-time polymerase chain reaction (PCR) assays for multiple tick and mosquito-borne pathogens such as Plasmodium knowlesi, Borrelia mayonii, Borrelia miyamotoi, Powassan virus and chikungunya virus.

She has also developed a multiplex PCR assay for the major human pathogenic microsporidia species that cause diarrhea and disseminated infections.

Most recently, Dr. Pritt has directed multiple research efforts to characterize two novel tick-borne pathogens that infect humans in the upper midwest region of the United States.

Dr. Pritt's work has resulted in the implementation of rapid and highly sensitive molecular tests for important human infections, including malaria, microsporidiosis, Lyme disease and Borrelia miyamotoi infection. Malaria, in particular, is a potentially fatal disease and a leading cause of infant mortality worldwide. In the U.S., malaria is most commonly seen in individuals who have traveled to or emigrated from endemic areas such as parts of Africa, Asia and South America.

Dr. Pritt also played a key role in discovering and describing two new tick-borne pathogens. In 2011, she described an Ehrlichia muris-like bacterium, and in 2016, she described a novel Borrelia species (Candidatus Borrelia mayonii), which causes Lyme disease. Both pathogens appear to be limited to the upper midwest region of the United States.

Joshua LaBaer is renowned for his work in proteomics and developing biomarker diagnostics. He leads ASU's COVID-19 research efforts. 

As executive director of the Biodesign Institute, his work emphasizes that multidisciplinary factors culminate to disease, suggesting personalized therapies and unique biomarker analysis. His team uses arrays to assess how programmable a protein is. This work also spans into epigenetics, and the capacity to modulate the activity of these proteins.

LaBaer was the founder and director of Harvard's Institute of Proteomics and a chairman of the Virginia G. Piper Center for Personalized Diagnostics. He is an associate editor of the Journal of Proteome Research, a member of the National Cancer Institute's Board of Scientific Advisors, chair of the Early Detection Research Network Steering Committee and recent president of the U.S. Human Proteome Organization.

Dr. S. Wesley Long received his MD degree in 2007 from The University of Texas Medical Branch (UTMB) in Galveston TX, where he also earned a PhD in Experimental Pathology. After finishing his doctoral studies, Dr. Long completed a clinical pathology residency at Houston Methodist. He currently serves as a member of the Editorial Board for Archives of Pathology and Laboratory Medicine. Dr. Long’s research centers on functional genomics of multidrug-resistant bacterial strains to identify novel drug targets. He is currently focusing his work on MRSA (methicillin-resistant Staphylococcus aureus) and Klebsiella pneumoniae, both of which readily acquire resistance to several different types of antibiotics and are prevalent in the hospital setting.

Bindu Mayi, M.Sc., Ph.D., is a professor of microbiology in NSU鈥檚 Dr. Kiran C. Patel College of Osteopathic Medicine, where she teaches infectious diseases to students in the medical, public health, and other allied health fields. In addition to her teaching responsibilities, Dr. Mayi is committed to promoting Infection Prevention as well as Antimicrobial Stewardship. 

She has been a spokesperson on various infections and has appeared on multiple panels attended by healthcare professionals and public officials, including representatives from the CDC. Dr. Mayi has provided comment and insight into a myriad of topics, including the Zika virus, the life threatening condition sepsis and necrotizing fasciitis (a.k.a. flesh eating disease). Most recently she has provided expert guidance and insight into the COVID-19 pandemic. She is well versed in working with the media (print and broadcast) and is comfortable on camera or, nowadays, via Zoom or Skype. She has also had several guest editorials published in newspapers across Florida.

Prior to her NSU affiliation, Dr. Mayi worked in antibiotic resistance research as well as cancer nanotechnology research. Dr. Mayi is passionate about medical education, especially prevention of infectious diseases. In 2008, Dr. Mayi was one of 80 women winners of the 鈥極-Whitehouse Leadership Project鈥�, where her project was prevention of MRSA in U.S. hospitals. 

Efrem Lim is an expert in viruses, biomedicine, microbiology and molecular biology.

He is a virologist and an assistant professor in the School of Life Sciences, and the Biodesign Center for Fundamental and Applied Microbiomics.

Lim's research focuses on viromes, microbiomes and the SARS-CoV-2 viral strain.

Professor Lim created the "Lim Lab" at ASU which integrates molecular virology and bioinformatics approaches in clinical cohorts.

Biologist Karen Guillemin is an internationally recognized expert in microbiology, cell and development biology, and host-microbe systems, and is developing new models to define host-microbe interactions in development and disease. Guillemin examines how hosts and their associated microbial communities shape each other, with the goal of understanding the principles by which complex host-microbe systems function and to learn how they can be manipulated to promote the health of human systems. 

Karen pioneered the use of zebrafish to study host-microbe interactions, including the influence of the gut microbiome on development, metabolism, and immunity.

A fellow in the American Association for the Advancement of Science, she serves as Phillip H. Knight Chair and professor of biology at the University of Oregon in the Institute of Molecular Biology. She has been on the faculty of the UO since 2001 and published more than 100 scientific papers.

Dr. Scott E. Baker leads the . His research interests include biotechnology, genomics, and genetics, especially as they relate to fungal metabolite production, enzyme secretion, and cell morphology. Baker has a joint appointment as a fungal biotechnology scientist with the U.S. Department of Energy (DOE) Joint BioEnergy Institute (JBEI) located in Emeryville, California. At JBEI, his research is focused on heterologous production of lignin active enzymes by fungi.
For more than a decade he has led and contributed to fungal genome projects, from single genomes, to resequencing of classical genetic mutant strains, to whole fungal genus sequencing efforts. In 2009 and 2010, with DOE Joint Genome Institute (JGI) staff members, he co-led the development and launch of the JGI Fungal Genomics Program.
Baker has served on the Board of Directors of Society for Industrial Microbiology and Biotechnology (SIMB) as both a Director and President, and is a recent SIMB Fellow. He has contributed to nine journals as a reviewer, has been on the editorial board for the Industrial Biotechnology journal since 2011, and guest edited numerous special edition journals.

Research Interests


Biotechnology
Biofuels and chemicals
Microbiology
Mycology


Education


PhD in Cell and Molecular Biology, Northwestern University, 1996
BS in Biology, Oregon State University, 1992

 is advancing animal health, biofuel production, and food safety through his research in microbiology. His work focuses on anaerobic microbiology and fermentations, molecular microbial ecology in gut ecosystems, degradation of plant cell wall polymers and biomass, nitrogen metabolism, anaerobic waste digestion, and antibiotic resistance genes.
Affiliations: 
Mackie is a professor in the , part of the  (ACES) at the . Mackie is also affiliated with the  in ACES and the .

Dr. Lisa Waidner, an Assistant Professor, has a Ph.D. from the College of Marine Science at the University of Delaware. Before she joined UWF in 2016, Waidner had the unique opportunity to work in several small biotechnology companies in the capacity of genetic engineering, phylogenetics, and directed evolution to improve biofuel and bioenergy-producing microorganisms.  Her academic mentors were Richard Karpel (UMBC, M.S. program), David Kirchman (Delaware, Ph.D. program), Thomas Hanson (Delaware, post-doctoral position), and co-mentors Robin Morgan and Joan Burnside (Delaware, post-doctoral fellowship). 
Her findings have been published in the Journal of Shellfish Research, Applied and Environmental Microbiology, Virology, and Environmental Virology. Topics have included aspects of Marek’s disease, virioplankton populations, and crab populations near the mouth of the Delaware Bay. Waidner’s current research interests are in environmental microbiology, microbial ecology, and bioremediation in oceans, coastal waters, inland bays, and rivers. 
These studies include developing a better understanding of global elemental cycles, as well as ‘applied’ bioremediation research.  Her work uses model bacteria called the aerobic anoxygenic phototrophs (AAP), which are a diverse group of proteobacteria that may be involved in light-stimulated uptake of dissolved organic matter and of point-source pollution and legacy contaminants.  Cultured and uncultured AAP are used in molecular biological, microbiological, and ecological studies on this diverse group of freshwater, estuarine, and marine bacteria. Dr. Waidner has taught classes in Introduction to Bioinformatics and Environmental Genomics and is currently a UWF instructor for Genetics Lab.  She is now working with undergraduate students to characterize unique AAP bacteria from coastal and inland waters in and around the Pensacola Bay system.

 
Brenda Anne Wilson is a Professor of microbiology in the School of Molecular & Cellular Biology at the University of Illinois Urbana-Champaign. She also is the Inaugural Professor of Biomedical and Translational Sciences in the Carle Illinois College of Medicine, an adjunct professor of pathobiology in the College of Veterinary Medicine; and the Sandia Senior Faculty Fellow in the university's Office of the Vice Chancellor for Research and Innovation. 
Wilson is a fellow of the American Academy of Microbiology and a member of the AAM Selection Committee, and an American Society for Microbiology Distinguished Lecturer.
She was a DAAD graduate exchange Fellow in biochemistry at Ludwig-Maximilians Universität München, Germany. While earning her PhD at Johns Hopkins University, she was an AAUW doctoral fellow and studied antibiotic biosynthesis. She then undertook her NIH postdoctoral fellowship training in microbiology at Harvard Medical School, where she began her studies on bacterial protein toxins. Her first tenured faculty appointment was in biochemistry at Wright State University School of Medicine, Dayton, Ohio.
As inaugural leader of the Host-Microbe Systems Theme of the Woese Institute for Genomic Biology at the University of Illinois for 10 years, Wilson brought together faculty and scientists from multiple disciplines across campus, including microbiology, anthropology, animal sciences, engineering, and veterinary pathobiology to forge new areas of microbiome research. She served for 10 years on the executive committee of the Great Lakes Regional Center for Excellence in Biodefense and Emerging Infectious Diseases. As co-director of the University of Illinois Center for Zoonoses Research, she has promoted the One-Health Initiative and training of DVM students in research through summer training experiences. For nearly 20 years she has served as Biosecurity Leader of the Executive Committee of the University of Illinois Program in Arms Control, Domestic and International Security, where she has engaged events promoting scientific literacy and bridging the gap between scientists and educators, policy makers, government officials, and the public.
Wilson is currently president of the Champaign-Urbana Branch of the American Association for University Women, where she helps organize and convene community outreach events aimed at advancing equity and higher education opportunities for women and girls, particularly in STEM areas. As director for undergraduate education in the School of Molecular and Cellular Biology, she helps oversee the delivery of all academic, advising, and curricular aspects of the BS in MCB, BS in Biochemistry, BS in Neuroscience, and the forthcoming BS in MCB + Data Science undergraduate programs and the MS in MCB graduate programs. As the Sandia Senior Faculty Fellow in the Office of the Vice-Chancellor for Research and Innovation, she fosters, engages, and sustains research collaborations in STEM disciplines, including building workforce pipelines between scientists at the University of Illinois and the U.S. Department of Energy's national labs.
Research interests
Wilson’s research focuses on the host-microbe interface, bacterial pathogenesis and bacterial protein toxins, development of anti-toxin and toxin-based therapeutic biologics, comparative and functional genomic technologies and applications involving microbiomes and their roles in health and disease, climate change impacts on microbiomes, health, and disease transmission, and development of technologies and applications for detection and risk assessment of Dual Use Research of Concern (DURC) objects, publications, and activities. She has published over 150 scientific articles, chapters, and books, including the highly acclaimed textbook Bacterial Pathogenesis: A Molecular Approach (4th Edition, 2019, ASM Press/John Wiley) and the recent Revenge of the Microbes: How Bacterial Resistance is Undermining the Antibiotic Miracle (2nd Edition, 2023, ASM Press/John Wiley).
Education
BA (Biochemistry and German), Barnard College/Columbia University, 1981
Biochemistry Diplomarbeit (Post-baccalaureate Program), Deutscher Akademischer Austauschdienst (DAAD), Ludwig-Maximilians Universität, Munich, Germany, 1981-1982
M.S./Ph.D. (Chemistry), Johns Hopkins University, 1989
Postdoctoral (Microbiology and Molecular Genetics), Harvard Medical School, 1989-1993
Website

Rowley earned his B.A. at the University of Warwick in England, which introduced him to the fascinating aspects of microbiology and biochemistry. After working in the food safety industry, he began a doctorate program studying the biology of bacterial viruses and the molecular mechanisms of the phiC31 integrase protein at the University of Aberdeen in Scotland.

Upon relocating to Texas, he studied the molecular mechanisms of a recombinase from a parasitic yeast plasmid and the replication of viruses that infect fungi and primates. He continued this work as a postdoc at the Biofrontiers Institute at Colorado University Boulder, CO. These projects gave  Rowley a broad base of expertise used techniques from molecular biology, biochemistry and evolution, that are applied in his current research projects.

Herrick studies the incidence and genomics of foodborne pathogens, such as Salmonella, in the environment, particularly streams and rivers. He has a special interest in the transmission of antibiotic resistance among bacteria. He is co-director of the Center for Genome and Metagenome Studies (CGEMS) at JMU.
He received his doctorate in microbiology from Cornell University and did postdoctoral research at Los Alamos National Laboratory in New Mexico. He also has bachelor's and master's degrees from Brigham Young University.